SAB Biotherapeutics (SABS) Amortizatization of Intangibles (2021 - 2026)
SAB Biotherapeutics (SABS) reported Amortizatization of Intangibles of $22000.0 for Q1 2026, little changed on a YoY basis from $22000.0 in Q1 2025, and down 36.93% quarter-over-quarter from $34883.0 in Q4 2025.
SAB Biotherapeutics (SABS) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
SAB Biotherapeutics has reported Amortizatization of Intangibles for 6 years, with the latest figure at $22000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles changed 0.0% year-over-year to $22000.0; the trailing twelve-month figure through Mar 2026 stood at $100883.0 (changed 0.12% YoY), and the FY2025 full-year result was $100000.0, changed 0.0% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $22000.0, down from $34883.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $41207.0 in Q1 2022, with the low at $2267.0 in Q4 2022.
- Historically, Amortizatization of Intangibles has averaged $24441.7 across 5 years, with a median of $22000.0 in 2023.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles sank 94.5% — and 2023, when it jumped 866.48%.
- SAB Biotherapeutics' Amortizatization of Intangibles stood at $2267.0 in 2022, then jumped by 866.48% to $21910.0 in 2023, then soared by 59.74% to $35000.0 in 2024, then declined by 0.33% to $34883.0 in 2025, then slumped by 36.93% to $22000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $22000.0 (Q1 2026), $34883.0 (Q4 2025), and $22000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | SAB Biotherapeutics | 214.77 Mn | 214.77 Mn | - | 22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 34,883.00 |
| Dec 31, 2025 | 34,883.00 |
| Sep 30, 2025 | 22,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Dec 31, 2024 | 35,000.00 |
| Dec 31, 2024 | 35,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 21,910.00 |
| Dec 31, 2023 | 21,910.00 |